Insider · CIK 0001478916
John P. Schmid
directorother
Files at ANAB (ANAPTYSBIO, INC), DSGN (Design Therapeutics, Inc.), BBOT (BridgeBio Oncology Therapeutics, Inc.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 6, 2026 | ANAB ANAPTYSBIO, INC | AGrant or award Stock Option (right to buy)derivative | +5,500 | $0.00 | $0 | 5,500 | Jan 8, 2026 |
| Jan 6, 2026 | ANAB ANAPTYSBIO, INC | AGrant or award Restricted Stock Unitderivative | +4,000 | $0.00 | $0 | 4,000 | Jan 8, 2026 |
| Dec 23, 2025 | ANAB ANAPTYSBIO, INC | JOther Common Stockindirect: By ESOP | -11,068 | $51.00 | $564k | 0 | Dec 23, 2025 |
| Aug 11, 2025 | BBOT BridgeBio Oncology Therapeutics, Inc. | MOption exercise Common Stock | +30,000 | - | - | 30,000 | Aug 11, 2025 |
| Aug 11, 2025 | BBOT BridgeBio Oncology Therapeutics, Inc. | MOption exercise Class B ordinary sharesderivative | -30,000 | $0.00 | $0 | 0 | Aug 11, 2025 |
| Jun 15, 2025 | ANAB ANAPTYSBIO, INC | MOption exercise Common Stock | +6,030 | $0.00 | $0 | 52,267 | Jun 17, 2025 |
| Jun 15, 2025 | ANAB ANAPTYSBIO, INC | MOption exercise Restricted Stock Unitderivative | -6,030 | $0.00 | $0 | 0 | Jun 17, 2025 |
| Jun 10, 2025 | DSGN Design Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +19,000 | $0.00 | $0 | 19,000 | Jun 12, 2025 |
| Mar 25, 2025 | ANAB ANAPTYSBIO, INC | JOther Common Stockindirect: By ESOP | +11,068 | $18.18 | $201k | 11,068 | Mar 27, 2025 |
| Jan 13, 2025 | ANAB ANAPTYSBIO, INC | MOption exercise Common Stock | +21,692 | $4.55 | $99k | 25,592 | Jan 15, 2025 |
| Jan 13, 2025 | ANAB ANAPTYSBIO, INC | MOption exercise Common Stock | +20,645 | $8.54 | $176k | 46,237 | Jan 15, 2025 |
| Jan 13, 2025 | ANAB ANAPTYSBIO, INC | MOption exercise Stock Option (right to buy)derivative | -21,692 | $0.00 | $0 | 0 | Jan 15, 2025 |
| Jan 13, 2025 | ANAB ANAPTYSBIO, INC | MOption exercise Stock Option (right to buy)derivative | -20,645 | $0.00 | $0 | 0 | Jan 15, 2025 |
| Jan 7, 2025 | ANAB ANAPTYSBIO, INC | AGrant or award Stock Option (right to buy)derivative | +16,510 | $0.00 | $0 | 16,510 | Jan 7, 2025 |
| Jan 7, 2025 | ANAB ANAPTYSBIO, INC | AGrant or award Restricted Stock Unitderivative | +6,030 | $0.00 | $0 | 6,030 | Jan 7, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.